1.25 ML hyaluronidase, human recombinant 160 UNT/ML Injection
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
1.25 ML hyaluronidase, human recombinant 160 UNT/ML Injection
160 UNT/ML · Injection · injection
A form of hyaluronidase, human recombinant →
1.25 ML hyaluronidase, human recombinant 160 UNT/ML Injection — Enzymes. Strength, form, class, interactions & more.
Active ingredient
Classification
EnzymesEndoglycosidase
Drug interactions
Hyaluronidase may reduce the effectiveness of medications that bind to the human neonatal Fc receptor.
- majorimmunoglobulin products — lower systemic exposures and reduce effectiveness
- majormonoclonal antibodies — lower systemic exposures and reduce effectiveness
- majorantibody derivatives containing the human Fc domain of the IgG subclass — lower systemic exposures and reduce effectiveness
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication